Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

O-GlcNAcylation licenses RNF166 to degrade the M protein of porcine coronaviruses.

Created on 01 Oct 2026

Authors

Runhui Qiu, Yucheng Zhang, Junwei Zhou, Jianan Wang, Wenbing Tang, Xinliang Xie, Yan Cheng, Tong Ding, Peng Sun, Yuting Shi, Caili Xi, Yanrong Zhou, Liurong Fang, Shaobo Xiao

Published in

PLoS pathogens. Volume 22. Issue 6. Pages e1014301. Epub Jun 25, 2026.

Abstract

Uridine diphosphate N‑acetylglucosamine (UDP‑GlcNAc) has often been overlooked because its source pathway contributes little to glucose flux. However, through O‑GlcNAcylation, even small fluctuations in UDP‑GlcNAc levels can be amplified to shape immune responses. In this study, we utilized porcine deltacoronavirus (PDCoV), an emerging enteropathogenic coronavirus with zoonotic potential, as a model to investigate the role of UDP-GlcNAc in viral infection. Our findings demonstrate that upon PDCoV infection, host cells increase the synthesis of UDP-GlcNAc, which inhibits viral replication by remodeling metabolic pathways. Mechanistically, O-linked N-acetylglucosamine transferase (OGT) transfers an O-GlcNAc moiety from UDP-GlcNAc to RNF166 at T157, resulting in O-GlcNAcylation. This modification enables RNF166 to ubiquitinate the PDCoV membrane (M) protein at K207, thereby promoting its degradation via the ubiquitin-proteasome pathway. Notably, these effects are common in the host response to porcine coronavirus infections, highlighting the intricate interplay among metabolism, glycosylation, and ubiquitination in immune responses.

PMID:
42348500
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement